Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Peri-procedural Pain in IR Procedures
NCT07535411Phase 4Not yet recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- May 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of liposomal bupivacaine in pain, sponsored by Massachusetts General Hospital. Primary endpoint: Patient-reported pain intensity. Planned start May 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT07535411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07535411.